title: Funding may influence trial results examining probiotics and Clostridium difficile diarrhea rates.
authors.affiliation: Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kolber
authors.affiliation: Alberta Research Centre for Health Evidence (ARCHE), Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Ben
authors.initials: B
authors.lastname: Vandermeer
authors.affiliation: Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: G Michael
authors.initials: GM
authors.lastname: Allan
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016360:Clostridioides difficile / Q000472:pathogenicity*; D003967:Diarrhea / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007297:Inpatients / Q000706:statistics & numerical data*; D008297:Male; D019936:Probiotics / Q000627:therapeutic use*; D012440:Saccharomyces
chemical_list: D000900:Anti-Bacterial Agents